Nanoparticles for Drug Delivery, Tissue Targeting and Imaging Analysis
- 技術優勢
- Nanoparticle synthesis does not require pre-purification of reagents or detergent solubilization of components Allows for the production of membrane proteins that can be captured as isolated as soluble entities Utilizes entirely cell-free processes and technologies Telo-NLP nanoparticles can execute site specific attachment/immobilization though telodendrimer-based chemistry, which means that no antibodies or fusion protein tags are required to immobilize the nanoparticles on any desired surface Telo-NLP nanoparticles use non-antigenic material The final size and monodispersity of the nanoparticles can be selected for by varying the ratio of telodendrimer-to-lipid concentrations, or varying the telodendrimers themselves Multiple types of telodendrimers can be used in synthesis to allow for multifaceted functions, including tumor targeting or drug delivery Novel size and stable compound
- 技術應用
- Supporting membrane proteins, small molecules, hydrophobic drugs and other moieties for targeting specific tissues and tumors for drug treatment and drug developmentRapid design and production of in vivo targeting, imaging and therapeutic delivery of biologically active molecules though direct surface conjugation to the telodendrimersEffective drug delivery system that can further increase drug efficacy
- 詳細技術說明
- Nanolipoprotein particles (NLPs) are nanoscale patches of lipid bilayer stabilized by peripheral scaffold. NLPs have distinct advantages over currently used membrane systems in terms of particle size and consistency. Currently, the greatest use of NLPs has been the stabilization and characterization of membrane proteins. Researchers at the University of California, Davis have developed a novel nanoparticle. When used to synthesize NLPs, these nanoparticles allow for NLPs to be used in in vivo drug delivery, tissue/cancer targeting, and imaging analysis. Additionally this technology also provides important information about the structure and function of membrane-bound proteins in water soluble particles that mimic the hydrophobic cell membrane. The combination of lipoprotein, lipids, and telodendrimers creates highly homogenous nanoparticles throughout the NLP, which has not been achieved by other means. Researchers at the University of California, Davis have developed a novel nanoparticle. When used to synthesize NLPs, these nanoparticles allow for NLPs to be used in in vivo drug delivery, tissue/cancer targeting, and imaging analysis. Additionally this technology also provides important information about the structure and function of membrane-bound proteins in water soluble particles that mimic the hydrophobic cell membrane. The combination of lipoprotein, lipids, and telodendrimers creates highly homogenous nanoparticles throughout the NLP, which has not been achieved by other means.
- *Abstract
-
Nanoparticles made of lipoproteins, lipids, and telodendrimers for in vivo drug delivery, tissue/cancer targeting, and imaging analysis.
- *IP Issue Date
- May 9, 2017
- *Principal Investigation
-
Name: Matthew Coleman
Department:
Name: Wei He
Department:
Name: Paul Henderson
Department:
Name: Kit Lam
Department:
Name: Juntao Luo
Department:
Name: Matthew Coleman
Department:
Name: R. Holland Cheng
Department:
Name: Li Xing
Department:
- 申請號碼
- 9644038
- 其他
-
Additional Technologies by these Inventors
- Ligands for Alpha-4-Beta-1 Integrin
- Three-Dimensional Cell Adhesion Matrix
- A Novel RGD-Containing Cyclic Peptide for use in Cancer Imaging and as a Targeted-Therapy Ligand
- Functional Illumination in Living Cells
- Nanoporphyrin Nanoparticles for Combination Phototherapy and Drug Delivery to Infantile Hemangiomas
- Early Detection of Ovarian Cancer Using Markers to Short Chain Carbohydrates
- PVA Nanocarrier System for Controlled Drug Delivery
- Site-Specific Ligation and Compound Conjugation to Existing Antibodies
- Novel Solid Tumor Chemodrug LLS2
- High Throughput Label-Free One-Bead-One-Compound (OBOC) Screening Assay
- Ligands for Improved Angiogenesis and Endothelialization of Blood Contacting Devices
- PTUPB Compound Potentiates Cisplatin-Based-First Line Therapies with No Additional Toxicity
- Proteoglycan Mimetics For Enhanced Wound Healing Angiogenesis And Vascular Repair
Tech ID/UC Case
24124/2010-279-0
Related Cases
2010-279-0
- 國家/地區
- 美國

欲了解更多信息,請點擊 這裡